Xylazine is an agonist at kappa opioid receptors and exhibits sex-specific responses to opioid antagonism
Article in Addiction Neuroscience (May 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Article in Addiction Neuroscience (May 2024)
Article in Psychoactives (March 2024)
Preprint in medRxiv (March 2024)